Skip to main content

Table 5 P Results of robustness of OLP and SMD

From: A validated RP-UPLC method for estimation of Samidorphan and Olanzapine in mixed powder and combined tablets

Parameter

Variation

OLP

SMD

Peak Area *(Mean ± SD)

% RSD

Plate Count

Tailing

Peak Area *(Mean ± SD)

% RSD

Plate Count

Tailing

Mobile phase (± 1 mL)

71:29

626,632 ± 4266.0

0.7

2787

1.73

260,172 ± 1968.9

0.8

3435

1.57

 

69:31

401,774 ± 1345.3

0.3

2612

1.74

242,845 ± 760.9

0.3

3302

1.66

Temperature (± 5ºC)

25 °C

315,006 ± 346.3

0.1

2691

1.71

195,916 ± 534.7

0.3

3283

1.63

 

35 °C

343,675 ± 2069.0

0.6

2659

1.75

211,199 ± 1182.7

0.6

3039

1.59

Flow rate (± 0.1 mL/min)

0.2

323,962 ± 1868.4

0.6

2710

1.68

204,923 ± 843.0

0.4

3372

1.65

 

0.4

285,488 ± 661.6

0.2

2602

1.75

181,521 ± 359.1

0.2

3231

1.53

  1. *Average of six replicates of standard solution